Objective. To describe the clinical, laboratory, radiologic, and histopathologic features of
methotrexate (MTX)‐induced lung injury in a combined cohort of selected patients with …

Rheumatoid arthritis (RA) is a progressive, systemic autoimmune disorder characterized by
articular and extra-articular manifestations. The lung is commonly a site of extra-articular …

OBJECTIVE: To investigate the occurrence of extraarticular manifestations (ExRA) in a well
defined community based cohort of patients with rheumatoid arthritis (RA), and to examine …

PURPOSE: To evaluate computed tomographic (CT) findings of rheumatoid arthritis–related
lung disease and categorize findings according to pathologic features. MATERIALS AND …

Background: Toxicity limits the use of methotrexate. Objective: To identify risk factors for
methotrexate-induced lung injury in patients with rheumatoid arthritis. Design: Case-control …

1. INTRODUCTION 1.1 An overview of the ILD guideline Since the publication of the first
BTS guidelines for diffuse lung disease nearly 10years ago, 1 the specialty has seen …

Objective. To determine the prevalence and important clinical predictors of radiographic and
physiologic abnormalities indicative of rheumatoid arthritis interstitial lung disease (RA‐ILD) …

Collagen vascular diseases that demonstrate features of interstitial lung disease include
systemic lupus erythematosus, rheumatoid arthritis, progressive systemic sclerosis …

Rheumatoid arthritis (RA) is a common, functionally disabling disease with genetic and
environmental contributors. It occurs in approximately 1% of the population and adversely …

Extra‐articular RA (ExRA) includes a wide variety of disease manifestations. Although
rheumatologists in general are aware that such events are clinically important, the …